Azerbaijan vs Mali: The number of people with susceptibility test result for rifampicin
Azerbaijan
1,409
in 2021
Mali
1,234
in 2021
Azerbaijan rank
59th
Mali rank
61st
The number of people with susceptibility test result for rifampicin over time
- Azerbaijan
- Mali
How they compare
Azerbaijan currently reports 1,409 against 1,234 in Mali, a difference of 175.
That makes Azerbaijan's figure about 1.1 times Mali's.
The two have swapped places 2 times across 5 shared years of data; in 2017 it was Azerbaijan ahead.
Azerbaijan ranks 59th and Mali ranks 61st of 155 countries.
Across the 2 decades both report, Azerbaijan averaged higher in 1 and Mali in 1.
Head to head by decade
| Decade | Azerbaijan | Mali | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1,956 | 141 | 1,815 | Azerbaijan |
| 2020s | 1,327 | 1,823 | 496 | Mali |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Azerbaijan or Mali?
- Azerbaijan, at 1,409 against 1,234 in Mali as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Azerbaijan and Mali?
- 175, with Azerbaijan ahead.
- How many years of comparable data are there for Azerbaijan and Mali?
- 5 years are reported by both, from 2017 to 2021.
- How do Azerbaijan and Mali rank globally for the number of people with susceptibility test result for rifampicin?
- Azerbaijan ranks 59th and Mali ranks 61st of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.